XML 28 R17.htm IDEA: XBRL DOCUMENT v3.25.1
Equity Investments
9 Months Ended
Apr. 30, 2025
Cash and Cash Equivalents [Abstract]  
Equity Investments

Note 7—Equity Investments

 

Equity investments consist of the following:

 

   April 30, 2025   July 31, 2024 
   (in thousands) 
Zedge, Inc. Class B common stock, 42,282 shares at April 30, 2025 and July 31, 2024  $102   $153 
Rafael Holdings, Inc. (“Rafael”) Class B common stock, 278,810 shares at April 30, 2025 and July 31, 2024   441    416 
Other marketable equity securities   106    70 
Fixed income mutual funds   4,538    4,370 
           
Current equity investments  $5,187   $5,009 
           
Visa Inc. Series C Convertible Participating Preferred Stock (“Visa Series C Preferred”)  $902   $695 
Visa Inc. Series A Convertible Participating Preferred Stock (“Visa Series A Preferred”)       877 
Convertible preferred stock—equity method investment   258    1,338 
Hedge funds   3,019    2,883 
Other   2,725    725 
           
Noncurrent equity investments  $6,904   $6,518 

 

Howard S. Jonas, the Chairman of the Company and the Chairman of the Company’s Board of Directors is also the Vice-Chairman of the Board of Directors of Zedge, Inc. and the Chairman of the Board of Directors, Executive Chairman, Chief Executive Officer, and President of Rafael.

 

In June 2025, pursuant to Rafael’s rights offering that was announced on April 29, 2025, the Company purchased 168,122 shares of Rafael Class B common stock for an aggregate of $0.2 million.

 

In June 2016, upon the acquisition of Visa Europe Limited by Visa, Inc. (“Visa”), IDT Financial Services received 1,830 shares of Visa Series C Preferred among other consideration. In July 2024, in connection with Visa’s mandatory release assessment, the Company received 33 shares of Visa’s Series A Preferred. In August 2024, the 33 shares of Visa Series A Preferred were converted into 3,300 shares of Visa Class A common stock, which the Company sold for $0.9 million.

 

 

The changes in the carrying value of the Company’s equity investments without readily determinable fair values for which the Company elected the measurement alternative was as follows:

 

   2025   2024   2025   2024 
  

Three Months Ended

April 30,

  

Nine Months Ended

April 30,

 
   2025   2024   2025   2024 
   (in thousands) 
Balance, beginning of period  $1,161   $1,719   $964   $1,632 
Adjustment for observable transactions involving a similar investment from the same issuer   10    (25)   207    162 
Upward adjustment               130 
Redemption               (230)
Impairments                
                     
Balance, end of the period  $1,171   $1,694   $1,171   $1,694 

 

The Company adjusted the carrying value of the shares of Visa Series C Preferred it held based on the fair value of Visa Class A common stock, including a discount for lack of current marketability, which is classified as “Adjustment for observable transactions involving a similar investment from the same issuer” in the table above. The Certificate of Designation with respect to the shares of Visa Series C Preferred restricts the transferability of the shares, there is no public market for the shares, and none is expected to develop. The shares become fully convertible into shares of Visa Class A common stock in June 2028.

 

In addition, in the nine months ended April 30, 2024, in connection with the acquisition of Regal Bancorp by SR Bancorp, the Company received cash of $0.2 million in exchange for shares of Regal Bancorp common stock it held.

 

Unrealized gains (losses) for all equity investments measured at fair value included the following:

 

   2025   2024   2025   2024 
  

Three Months Ended

April 30,

  

Nine Months Ended

April 30,

 
   2025   2024   2025   2024 
   (in thousands) 
Net gains (losses) recognized during the period on equity investments  $359   $(78)  $1,133   $(280)
Less: net gains recognized during the period on equity investments sold during the period               130 
                     
Unrealized gains (losses) recognized during the period on equity investments still held at the reporting date  $359   $(78)  $1,133   $(410)

 

The unrealized gains and losses for all equity investments measured at fair value in the table above included the following:

 

   2025   2024   2025   2024 
  

Three Months Ended

April 30,

  

Nine Months Ended

April 30,

 
   2025   2024   2025   2024 
   (in thousands) 
Unrealized (losses) gains recognized during the period on equity investments:                    
Rafael Class B common stock  $(134)  $(61)  $25   $(115)
                     
Zedge Class B common stock  $(12)  $(36)  $(51)  $13 

 

Equity Method Investment

 

The Company has an investment in shares of convertible preferred stock of a communications company (the equity method investee, or “EMI”). As of both April 30, 2025 and July 31, 2024, the Company’s ownership was 33.4% of the EMI’s outstanding shares on an as converted basis. The Company accounts for this investment using the equity method since the Company can exercise significant influence over the operating and financial policies of the EMI but does not have a controlling interest.

 

The Company determined that on the dates of the acquisitions of the EMI’s shares, there were differences between its investment in the EMI and its proportional interest in the equity of the EMI of an aggregate of $8.2 million, which represented the share of the EMI’s customer list on the dates of the acquisitions attributed to the Company’s interest in the EMI. These basis differences are being amortized over the 6-year estimated life of the customer list. In the accompanying consolidated statements of income, amortization of equity method basis difference is included in the equity in the net loss of investee, which is recorded in “Other income (expense), net” (see Note 17).

 

 

The following table summarizes the change in the balance of the Company’s equity method investment:

 

   2025   2024   2025   2024 
  

Three Months Ended

April 30,

  

Nine Months Ended

April 30,

 
   2025   2024   2025   2024 
   (in thousands) 
Balance, beginning of period  $752   $1,932   $1,338   $2,784 
Purchase of convertible preferred stock   253    504    926    1,513 
Equity in the net loss of investee   (405)   (529)   (978)   (1,704)
Amortization of equity method basis difference   (342)   (342)   (1,028)   (1,028)
                     
Balance, end of the period  $258   $1,565   $258   $1,565 

 

In February 2025, the Company entered into a loan agreement with the EMI for a revolving credit facility. The aggregate principal amount available under the facility is $2.0 million. The loans will incur interest at 12% per annum payable semiannually and are due and payable in February 2027. In February 2025, the Company loaned the EMI $0.5 million under the revolving credit facility. In May 2025, the Company loaned the EMI an additional $0.4 million under the revolving credit facility.